We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » New FDA Programs Cut Down on Big Pharma Calls to CDER Ombudsman
New FDA Programs Cut Down on Big Pharma Calls to CDER Ombudsman
May 18, 2012
CDER has implemented new outreach programs that last year dramatically reduced the use of the agency’s ombudsman’s office — the main gateway for complaints against the center.